EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Lipid nanoparticle (LNP) mediated mRNA delivery in cardiovascular diseases: Advances in genome editing and CAR T cell therapy

Setareh Soroudi, Mahmoud Reza Jaafari, Leila Arabi

Journal of Controlled Release · 2024-08 · 372 · 113-140

DOI: 10.1016/j.jconrel.2024.06.023 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Controlled Release, 2024-08. Verfasst von Setareh Soroudi und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran; Student Research Committee, Mashhad University of Medical Sciences, Mashha…. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Gene Editing, Nanoparticles, RNA, Messenger. Die Arbeit wurde bisher 96-mal zitiert (Crossref) und nennt 301 Literaturangaben. Gefördert von: Mashhad University of Medical Sciences, AstraZeneca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesGene EditingNanoparticlesRNA, MessengerLipidsHumansAnimalsImmunotherapy, AdoptiveGene Transfer TechniquesCOVID-19Liposomes

Stichwörter der Autor:innen

Artificial intelligence (AI)CRISPR/CasCardiovascular diseases (CVDs)Chimeric antigen receptor (CAR)-T cellGenome editingHeart failure (HF)HypercholesterolemiaIonizable lipidsLipid nanoparticles (LNPs)Messenger RNA (mRNA) deliveryMyocardial infarction (MI)

Substanzen

RNA, MessengerLipid NanoparticlesLipidsLiposomes

Autor:innen und Institutionen

  • School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran; Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical…

Förderung

  • Mashhad University of Medical Sciences
  • AstraZeneca

Zitieren

APA

Soroudi, S., Jaafari, M. R., & Arabi, L. (2024). Lipid nanoparticle (LNP) mediated mRNA delivery in cardiovascular diseases: Advances in genome editing and CAR T cell therapy. Journal of Controlled Release, 372, 113-140. https://doi.org/10.1016/j.jconrel.2024.06.023

Vancouver

Soroudi S, Jaafari MR, Arabi L. Lipid nanoparticle (LNP) mediated mRNA delivery in cardiovascular diseases: Advances in genome editing and CAR T cell therapy. Journal of Controlled Release. 2024;372:113-140. doi:10.1016/j.jconrel.2024.06.023

BibTeX
@article{Soroudi2024,
  author = {Soroudi, Setareh and Jaafari, Mahmoud Reza and Arabi, Leila},
  title = {Lipid nanoparticle (LNP) mediated mRNA delivery in cardiovascular diseases: Advances in genome editing and CAR T cell therapy},
  journal = {Journal of Controlled Release},
  year = {2024},
  volume = {372},
  pages = {113--140},
  doi = {10.1016/j.jconrel.2024.06.023}
}
Kostenlos starten →